Clinical Trials · NCT06374875
Fibrosis Lessens After Metabolic Surgery
RecruitingPhase 4Tirzepatide (Investigational)Semaglutide (Investigational)Liraglutide (Investigational)
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- The Cleveland Clinic
- Enrollment
- 120
- Start date
- Jul 2024
- Locations
- 22 sites, 13 countries
- Primary endpoint
- Improvement of at least 1 fibrosis stage of the Kleiner fibrosis classification and no worsening of MASH in the repeat liver biopsy.